With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Immune Stimulatory Antigen Loaded Particles (ISAPS) for the Treatment of Solid Childhood Tumors||Children’s National Medical Center / Suzanne Miles||Young Investigator Grants||2009||District of Columbia|
|Optimizing EGFR targeted therapy in pediatric malignant glioma.||University of California San Francisco / Theodore Nicolaides||Young Investigator Grants||2009||California|
|Identification of FDA approved drugs with anti-tumor activity in rhabdomyosarcoma.||Massachusetts General Hospital / David Langenau||Young Investigator Grants||2009||Massachusetts|
|Genetic Regulators of ER Stress-induced Apoptosis in Pediatric Malignancies||Dana-Farber Cancer Institute / Ujwal Pyati||Young Investigator Grants||2009||Massachusetts|
|MLL-based chromosomal translocations in the pathogenesis of childhood leukemia.||Children’s Mercy / Erin Guest||Young Investigator Grants||2009||Missouri|
|Adaptation of acute lymphoblastic leukemia (ALL) to the post-transplant allogeneic environment.||University of Rochester / Craig Mullen||Innovation Grants||2009||New York|
|Linking mitogenic sonic hedgehog signaling to the oncogene Yap 1 in neural stem/progenitor cells and medulloblastoma.||Memorial Sloan-Kettering Cancer Center / Anna Kenney, PhD||Innovation Grants||2009||New York|
|Modeling anaplastic medulloblastoma using cerebellar stem cells||Duke University / Robert Wechsler-Reya, PhD||Innovation Grants||2009||North Carolina|
|Investigating the role of lin-28 in germ cell tumorigenesis||Boston Children’s Hospital / George Daley||Innovation Grants||2009||Massachusetts|
|BH3 profiling to define therapy resistance classes in neuroblastoma.||Children’s Hospital of Philadelphia / Michael Hogarty||Innovation Grants||2009||Pennsylvania|